Mar 2022 $10 M No. 5 $10 to $50 million 213
Lung Therapeutics, Inc.: Raise no. 5, Mar 2022 × Investors in this round 213 investors had bought by the notice of Apr 4, 2022: 213 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $15 M offered; $5 M still to sell
Smallest investment taken $15,000
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $855,525
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Brian Windsor · Executive Officer, Director Charles C. Garner · Executive Officer Aaron G.L. Fletcher · Director William C. Fairey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Newbridge Securities Corporation (CRD 104065) · Boca Raton, Florida Sold in AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, MA, MD, MI, MN, MO, NC, NJ, NY, OH, OK, PA, SC, TX, UT, VA, WA, WI Signed by Charles Garner, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 4, 2022. Read the notice at the SEC .
equity, options SEC May 2019 $39 M No. 4 $10 to $50 million 42
Lung Therapeutics, Inc.: Raise no. 4, May 2019 × Investors in this round 42 investors had bought by the notice of Oct 31, 2019: 42 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $39 M of $39 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice James Brian Windsor · Executive Officer, Director Aaron Brian Fletcher · Director R. A. Session · Director Robert Brian Mills · Director Steven Brian Idell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by J. Brian Windsor, President. Source: SEC Form D and 1 amendment, newest notice filed Oct 31, 2019. Read the notice at the SEC .
equity, options SEC Jun 2018 $4 M No. 3 $2 to $10 million 15
Lung Therapeutics, Inc.: Raise no. 3, Jun 2018 × Investors in this round 15 investors had bought by the notice of Jul 26, 2018: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice James Brian Windsor · Executive Officer, Director · President and CEO Aaron Brian Fletcher · Director Jim Brian Mervis · Director Robert Brian Mills · Director Steven Brian Idell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by J. Brian Windsor, President. Source: SEC Form D, newest notice filed Jul 26, 2018. Read the notice at the SEC .
options SEC Mar 2016 $14 M No. 2 $10 to $50 million 17
Lung Therapeutics, Inc.: Raise no. 2, Mar 2016 × Investors in this round 17 investors had bought by the notice of May 19, 2017: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $14 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice James Brian Windsor · Executive Officer, Director · President and CEO Aaron Brian Fletcher · Director Robert Brian Mills · Director Steven Brian Idell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by J. Brian Windsor, President. Source: SEC Form D and 2 amendments, newest notice filed May 19, 2017. Read the notice at the SEC .
equity SEC Sep 2014 $3 M No. 1 $2 to $10 million 3
Lung Therapeutics, Inc.: Raise no. 1, Sep 2014 × Investors in this round 3 investors had bought by the notice of Sep 30, 2015: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice James Brian Windsor · Executive Officer, Director · President and CEO Aaron Brian Fletcher · Director Joseph Brian Woelkers · Director Robert Brian Mills · Director Steven Brian Idell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by J. Brian Windsor, President. Source: SEC Form D and 1 amendment, newest notice filed Sep 30, 2015. Read the notice at the SEC .
equity, options SEC